Accuri Cytometers Inc. is a life sciences company developing and marketing revolutionary bench-top flow cytometer systems. On 08 July 2008, Accuri Cytometers announced the completion of a $13 million Series C financing led by Fidelity Biosciences and Flagship Ventures. For more information, visit www.AccuriCytometers.com.